May 11, 2014 |
Doctors who work with patients with bipolar disorder should keep in mind that those people are also at high risk for migraine headaches, a Pennsylvania State University researcher says. A new study led by Erika Saunders, executive vice-chair of psychiatry at the Penn State Milton S. Hershey Medical Center, found that people with bipolar disorder were far likelier than the general population to get migraines and that those who got the awful headaches were at risk for worse psychosocial functioning, more severe depression, and earlier onset of bipolar symptoms.
February 12, 2013 |
For years, neurologist William Young of Thomas Jefferson University Hospital's Headache Center has heard his patients say how bad they felt when other people did not take their migraines seriously. "Every day, I hear stories of the ignorant or mean-spirited things people say to them about having their disease," he said. "People make it obvious that they think they're morally weak because they're not functioning well because of a mere headache. " He says the federal government has the same attitude when it comes to researching the condition, which affects 12 percent of the adult population and can leave some people in terrible pain more days than not. So, when an intern asked about a research topic, Young jumped at the chance to study stigma in migraine patients.
June 19, 2012 |
Must the show always go on? In 18 years of theatergoing in Philadelphia, I had never been sent home at intermission because a company could not continue the production — until Saturday. That was when I attended Plays and Players' staging of Tom Stoppard's Travesties. After intermission, stage manager Rebecca Rose and public relations intern Sean Cummings took the stage to announce that actress Cathy Mostek (playing Vladimir Lenin's wife) had suffered a migraine and could not perform.
April 21, 2012 |
A dozen years ago, a patient told plastic surgeon Bahman Guyuron that her forehead lift made her feel fabulous. Sure, she looked better. But the wrinkle-smoothing operation also endedher migraine headaches, something that decades of drugs and lifestyle changes had failed to do. After a similar case of serendipity, Guyuron became intrigued by the possibility that he had stumbled on a new way to help some of the 36 million hapless Americans who...
April 12, 2012 |
DEAR ABBY: I'd like to respond to "Hurting in Virginia Beach, Va.," who complained that the smell of mint chewing gum triggers her migraines. I chew gum on planes because it helps reduce sinus pressure, thus preventing my own headaches. I am also a former smoker, and gum-chewing is a healthier alternative to tobacco. If "Hurting" explained her situation, I would certainly abide by her request to not chew, although I would find it uncomfortable to go without for long. I recommend she carry several packs of non-mint gum in her purse.
January 30, 2012 |
Items on Jeff Wojciechowski's to-do list before a 2010 family vacation to Cancun included renewing his passport, shopping for beach wear, and getting a Botox injection. The procedure wasn't to smooth out wrinkles. Instead, the injection went into his bladder muscle, to give the 63-year-old Fort Washington man a respite from incontinence that has plagued him since a 2006 construction accident left him paralyzed from mid-chest down. Though Botox has become synonymous with the temporary elimination of wrinkles, what's less well known is its application across medicine.
November 21, 2011 |
It goes without saying that the founders of NuPathe Inc. have a vested interest in seeing U.S. regulators one day approve the company's first product. But since chief executive officer Jane H. Hollingsworth and president Terri B. Sebree both suffer from migraines, they not only know their target market - they are their target market. Last week, the Conshohocken specialty-pharmaceutical company announced a new timetable for introducing its treatment for acute migraine, which they'd originally hoped would be on the market during the first half of 2012.
August 31, 2011 |
When you're a small public company, you usually don't want to be one of the day's most actively traded stocks. Invariably, it means bad news has unnerved investors. So it was Tuesday with NuPathe Inc. , a 61/2-year-old Conshohocken drug-development firm, when it disclosed that federal regulators had questions that will delay the launch of its first product. NuPathe said the Food and Drug Administration issued a complete-response letter in connection with its review of the migraine treatment Zelrix.
August 29, 2011 |
Lisa Scottoline will return next week. Italian women are stereotypically overreactors. My mother, for example, makes nuclear reactors seem reasonable. But I pride myself on being the coolheaded one. I can win any argument, or at least whip my mom into a frenzy, simply by remaining calm. So I always imagined I'd perform well in an emergency. I finally got my test case in last week's earthquake. I was writing on my laptop, when all of a sudden I felt as if the floor was swinging.
August 3, 2011
NuPathe Inc., a Conshohocken pharmaceutical company, said today that Aspire Capital Fund L.L.C. agreed to buy up to $30 million worth of NuPathe common stock over the next two years. Aspire, a Chicago investment company, started with a purchase of 70,000 shares for $500,000. The price was $7.07 a share, 19 percent more than the stock's closing price of $5.95 on Tuesday. In early afternoon trading today, the shares were down $1.34 at $4.61. NuPathe is developing medicines for diseases of the central nervous system.